LY3022855   Click here for help

GtoPdb Ligand ID: 9109

Synonyms: IMC-CS4
Immunopharmacology Ligand
Compound class: Antibody
Comment: LY3022855 (IMC-CS4) is a human IgG1 monoclonal antibody designed to target the CSF1R. It is being investigated for its potential anti-neoplastic action. LY3022855 is claimed in patent WO2011123381 [1], by Imclone Llc.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
References
1. Doody JF, Li Y. (2011)
Antibodies against csf-1r.
Patent number: WO2011123381 A1. Assignee: Imclone Llc. Priority date: 01/04/2010. Publication date: 06/10/2011.